Natesto Approval History

  • FDA approved: Yes (First approved May 28th, 2014)
  • Brand name: Natesto
  • Generic name: testosterone
  • Previous name: CompleoTRT
  • Company: Trimel Pharmaceuticals Corporation
  • Treatment for: Hypogonadism, Male

Natesto (testosterone) is a bioadhesive intranasal gel testosterone product for the treatment of male hypogonadism.

FDA Approval History for Natesto

DateArticle
May 29, 2014Approval FDA Approves Natesto (testosterone) Nasal Gel to Treat Men with Low Testosterone
Jul  9, 2013United States Food and Drug Administration Accepts Trimel's NDA for CompleoTRT

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web4)